RECALL DATABASE

Semaglutide Recall: ProRx 2 mL Multidose Vial

Announced 2025-11-05 · FDA

The FDA recalls ProRx Semaglutide Injection, 5 mg/2 mL, 2 mL multidose vials (Rx Only) due to lack of assurance of sterility. Lot PRORX052125-4, containing 2,805 vials, was distributed in Texas and Utah. Corrective action information is not provided in the notice.

BrandProRx LLC
ProductSemaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02
ReasonLack of Assurance of Sterility
Severitymoderate
Units affected8400
DistributionTX and UT
AgencyFDA

WHAT YOU SHOULD DO

  1. Do not use recalled vials.
  2. Check the lot number PRORX052125-4 on your vial to see if you are affected.
  3. Contact your healthcare provider or pharmacist for guidance and possible replacement.
  4. Follow the recall instructions from FDA and ProRx for returning or disposing of the recalled product.

How to identify the recalled item

Lot / date codesLot PRORX052125-4
Lot / date codesLot, Best Use Date (BUD): Lot PRORX050925-1, BUD November 4, 2025; Lot ProRx051425-5, BUD November 10, 2025; Lot ProRx051425-6, BUD November 10, 2025

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other semaglutide recalls

See every semaglutide recall →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.